登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《SSRN，2月5日，More Than Pneumonia, The Potential Occurrence of Multiple Organ Failure in?2019Novel?Coronavirus?Infection》

  • 来源专题：COVID-19科研动态监测
  • 编译者： xuwenwhlib
  • 发布时间：2020-02-07

  • More Than Pneumonia, The Potential Occurrence of Multiple Organ Failure in 2019 Novel Coronavirus Infection

    4 Pages Posted: 5 Feb 2020

    Ming Yang

    Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong

    Jinming Zhao

    Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University

    Zheng Zhang

    Department of Cardiology, PLA Rocket Force Characteristic Medical Center

    Date Written: February 5, 2020

    Abstract

    Angiotensin converting enzyme 2 (ACE2) in the lung has been recognized as the key receptor of the 2019 novel coronavirus (2019-nCoV) as people may get infected through the respiratory tract. However, the clinical features of other systems have not been addressed yet. More than the respiratory system, ACE2 also extensively expressed in the vascular endothelial cells of the heart, kidney, liver, intestine, and testis, etc. In other words, the new coronavirus may probably intrude on any tissues or organs as long as the needed number of ACE2 is available. Therefore, once exposed to the coronavirus (e.g. through the blood or other body fluid), these organs may also get affected especially for those the receptor has the direct-acting control. This paper aims to analyze the possibility of the association between 2019-nCoV infection and the multiple organ failure (MOF) other than pneumonia.

    Keywords: Angiotensin converting enzyme 2 (ACE2), 2019 novel coronavirus (2019-nCoV), blood-air barrier, multiple organ failure(MOF)

    Suggested Citation:

    Yang, Ming and Zhao, Jinming and Zhang, Zheng, More Than Pneumonia, The Potential Occurrence of Multiple Organ Failure in 2019 Novel Coronavirus Infection (February 5, 2020). Available at SSRN: https://ssrn.com/abstract=3532272 or http://dx.doi.org/10.2139/ssrn.3532272

  • 原文来源：https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3532272
34浏览量
原文链接
相关报告

  • 《SSRN，2月4日，Estimating the Number of 2019 Novel Coronavirus Cases in Chinese Mainland》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-02-06
    • Estimating the Number of 2019 Novel Coronavirus Cases in Chinese Mainland 15 Pages Posted: 4 Feb 2020 Huwen Wang Shanghai Jiao Tong University (SJTU) - School of Public Health Zezhou Wang Fudan University - Department of Oncology More... Abstract Background: An outbreak of clusters of viral pneumonia due to 2019 novel Coronavirus (2019-nCoV) happened in Wuhan, Hubei province in China in December 2019. Since the outbreak, 2 studies estimated the possible epidemic trend of the infection, but proved to be inconsistent with the actual confirmed number of cases. We intend to re-estimate the trend and peak arrival time for the 2019-nCoV infection transmission in Chinese mainland using the SEIR model, so as to provide theoretical basis for future prevention and control of the current epidemic in China. Methods: An infectious disease dynamics SEIR model was applied to forecast the epidemic’s development trend in China from 26 January 2020 based on data collected from the database reported by the National Health Commission. R0 were assumed to be 0.5, 0.25 and 0.125. Findings: The estimated numbers of cumulative cases would reach the peak on 3rd, 4th and 5th of February, 2020, which were 11,116, 11,373, 11,966, respectively, in Chinese Mainland. Similar peaks were also identified in Hubei Province, Wuhan City and other locations of China outside Hubei Province. The epidemic of 2019 novel Coronavirus was estimated to subside between early May (R0 = 0.125) and early August (R0 = 0.5). The estimated average number of deaths ranged from 344 to 1146. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    77浏览量
    原文链接

  • 《SSRN，2月6日，Clinical Course and Outcomes of Critically Ill Patients of 2019 Novel Coronavirus Pneumonia》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-02-07
    • Clinical Course and Outcomes of Critically Ill Patients of 2019 Novel Coronavirus Pneumonia 19 Pages Posted: 6 Feb 2020 Corresponding Author: You Shang, Ph.D., M.D. Wuhan Union Hospital Wuhan, Hubei CHINA First Author: Xiaobo Yang Abstract Background: An ongoing outbreak of pneumonia associated with the 2019 novel coronavirus (2019-nCoV) started in December 2019, in Wuhan, China. Information on critically ill patients of 2019-nCoV infection is extremely limited. We aimed to describe the clinical course and outcomes of critically ill patients of 2019-nCoV pneumonia. Methods: In this retrospective study, 52 critically ill patients out of 710 patients, who were diagnosed with 2019-nCoV pneumonia in Wuhan Jinyintan Hospital between the onset of the outbreak and January 26, 2020, were investigated. Only patients treated with high flow nasal cannula or mechanical ventilator were included. Patients who were deceased or who had been hospitalized for at least 14 days were considered for the case reviewed. Epidemiological, demographic, clinical and laboratory data were collected and analyzed to explore the differences between survivors and non-survivors. Findings: Of the 52 critically ill patients, the average age was 59.7 ±13.3 years(mean ± standard deviation), 35 (67.3%) were male, 21 (40.4%) had chronic illness, 51 (98.1%) had fever, 35 (67.3%) had ARDS and 37 (71.2%) required mechanical ventilation. The duration from onset of symptoms to radiological diagnosis of pneumonia was 5 [3-7] (median [interquartile range]) days. Thirty-three (57.7%) patients deceased, and the duration from hospital admission to death was 7 [3 - 11] days. Compared with survivors, non-survivors were older (64.7 ± 11.1 years vs 59.7 ± 13.3 years, p = 0.001), received higher fraction of oxygen therapy (0.87 ± 0.16 vs 0.70 ± 0.18, p = 0.004), developed more ARDS (83.3% vs 45.4%, p = 0.007), required more mechanical ventilation (93.3% vs 40.9%, p = 0.003) and were more likely to be on extracorporeal membrane oxygenation (16.7% vs 4.6%, p = 0.06).
    163浏览量
    原文链接